PUBLIC CONTRACT · 2025

Medicamentos usados em afeções oculares e otorrinolaringológicas

Contract value
€37,381.05
Signed on
6 November 2025
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 12692476

PUBLISHED SUBJECT

41/193/2026 - Medicamentos usados em afeções oculares e otorrinolaringológicas

Parties involved

Place of performance
Portugal, Faro, Faro
NUTS region
PT150 - Algarve

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee
THEA PORTUGAL S.A. · Tax ID 507978358
Awardee
Davi II - Farmacêutica, S.A. · Tax ID 508309450
Awardee
LAB. EDOL - Produtos Farmacêuticos, SA · Tax ID 507072642
Awardee
GlaxoSmithKline-Prod.Farm.Lda · Tax ID 500139962

Values and timeline

Contract price
€37,381.05
Procedure base price
€37,381.05
Total effective price
Not reported on Portal BASE
Publication date
20 January 2026
Award date
6 November 2025
Signing date
6 November 2025
Performance period
365 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type
Aquisição de bens móveis
Procedure type
Ao abrigo de acordo-quadro (art.º 259.º)
Award criterion
Monofator
CPV code
33690000-3 - Medicamentos vários
Legal basis
Artigo 259.º do Código dos Contratos Públicos
Regime
Código dos Contratos Públicos ( DL 111-B/2017 )
Framework agreement
782/2024 - Concurso público internacional para formação do acordo-quadro de medicamentos usados em afeções oculares e otorrinolaringológicas
Centralised procedure
No
Environmental criterion
No
Notice
Not stated
Procedure identifier
8760900

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts